Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use
ST. LOUIS, Feb. 06, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, announced today that beginning Friday, April 5, 2024, Ioflupane I 123 Injection will be available for Friday patient administration in the US. This additional day of production allows customers to access the product and capitalize on early morning availability on … Read more
